Vaccine Authorisation

29 January 2021 |

The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by AstraZeneca, the third COVID-19 vaccine authorised in the EU.

Read more at the link below.

RELATED LINKS

ENTERPRISE GREECE
profile icon

Company Profile

READ MORE
dioikitiko simvoulio icon

Board of Directors

READ MORE
diktio sinergaton icon

Stakeholder Network

READ MORE
epikoinonia icon

Contact us

READ MORE

LOGIN